Skip to content

NVS

Novartis AG

NYSE · Healthcare · Drug Manufacturers - General · CH

$140.37
−0.39%
Ask drillr

Next report

Analyst consensus

Next report date
Oct 27, 2026
EPS estimate
$2.24
Revenue estimate
$14.6B

Latest reported

Last report date
Jul 21, 2026
EPS actual
$2.41
EPS estimate
$2.17
Revenue actual
$14.4B
Revenue estimate
$14.1B

Track record

Trailing twelve quarters

EPS beats (12Q)
9
EPS misses (12Q)
3
EPS in line (12Q)
0
Avg surprise (4Q)
+2.3%
Revenue beats (12Q)
7
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Jul 21, 2026$2.17$2.41Beat 11.06%$14.4B
Apr 28, 2026$2.11$1.99Miss -5.69%$13.1B
Feb 4, 2026$1.99$2.03Beat 2.01%$13.3B
Jul 17, 2025$2.38$2.42Beat 1.68%$14.3B
Jan 31, 2025$1.80$1.98Beat 10.00%$13.6B
Jul 18, 2024$1.89$1.97Beat 4.23%$12.5B
Jan 31, 2024$1.64$1.53Miss -6.71%$11.8B
Jul 18, 2023$1.68$1.83Beat 8.93%$13.9B
Feb 1, 2023$1.42$1.51Beat 6.34%$13.1B
Jul 19, 2022$1.51$1.56Beat 3.31%$13.1B
Feb 2, 2022$1.44$1.40Miss -2.78%$13.5B
Jul 21, 2021$1.53$1.66Beat 8.50%$13.3B

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 27, 2026